Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants. Banerjee et al.
Published: 31 March 2022| Version 1 | DOI: 10.17632/mfvm8fwf3s.1
Supplemental supporting data for phylogeny generation, frequency of mutations, and description of serum samples. Table S1. Metadata for phylogenetic analysis, Related to Figure 1. Table S2. Frequency of mutations (percentage read support) across the full genome of clinical isolates of beta, delta and omicron variants used in this study, Related to Figure 1. Table S3. Serum samples from different cohorts, Related to Figure 2 and 3.
University of Saskatchewan
Virus, Neutralizing Antibody, Severe Acute Respiratory Syndrome Coronavirus 2